We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Paragon 28 Inc (FNA) COM USD0.01

Sell:$5.84 Buy:$6.17 Change: $0.22 (3.89%)
Market closed |  Prices as at close on 4 October 2024 | Switch to live prices |
Sell:$5.84
Buy:$6.17
Change: $0.22 (3.89%)
Market closed |  Prices as at close on 4 October 2024 | Switch to live prices |
Sell:$5.84
Buy:$6.17
Change: $0.22 (3.89%)
Market closed |  Prices as at close on 4 October 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Paragon 28, Inc. is a medical device company focused on the foot and ankle orthopedic market. The Company provides orthopedic solutions, procedural approaches and instrumentation that cover a range of foot and ankle ailments, including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot and orthobiologics. To treat these painful, debilitating or even life-threatening conditions, it provides a portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. Its broad suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. It has developed a comprehensive portfolio of foot and ankle surgical systems. Each system typically includes plates, screws, staples, nails, advanced joint and bone replacements, orthobiologics, and other implantation instruments and disposables specifically designed for the particular surgical system.

Contact details

Address:
14445 Grasslands Drive
ENGLEWOOD
80112
United States
Telephone:
+1 (720) 9121332
Website:
https://paragon28.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
FNA
ISIN:
US69913P1057
Market cap:
$496.85 million
Shares in issue:
83.50 million
Sector:
Health Care Equipment
Exchange:
-
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Albert Dacosta
    Chairman of the Board, President, Chief Executive Officer
  • Kristina Wright
    Interim Chief Financial Officer, Director
  • Drew Hill
    Executive Vice President - Research and Development
  • Erik Mickelson
    Chief Accounting Officer, Controller
  • Robert Mccormack
    General Counsel, Corporate Secretary
  • Matthew Jarboe
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.